A. Sethi et al. / Journal of Molecular Structure xxx (2016) 1e7
3
d
d
d
d
1.862 (1H, m, H-1
2.534 (1H, d, H-2
2.504 (1H, m, H-6
a
b
),
),
d
2.222 (1H,m, H-1
5.690 (1H, s, H-4),
1.143 (1H, m, H-7 ),
b
),
d
d
d
2.317 (1H, m, H-2
2.271 (1H, d, H-6
2.001 (1H, m, H-7
a
a
b
),
),
),
and chloroform/methanol (98:2) as eluent yielding 5.6 mg (86.15%)
of compound 4 as white crystalline solid. m.p: 482 K, Molecular
d
b
),
d
a
formula: C35H42O7, 1H NMR in CDCl3 at 300 MHz (ppm):
d
7.260 (D,
1.013e0.976 (1H, dd, H-9, J ¼ 3.3
1.624 (3H, d, H-24, J ¼ 7.2), 3.911 (3H, s,
3.959 (1H, q, H-23, J ¼ 6.9 Hz, 7.2 Hz), 4.428e4.408 (1H,
q, J ¼ 3 Hz, H-11), 4.800 (1H, d, J ¼ 17.4, H-21A), 5.046 (1H, d,
5.676 (1H, d, H-4, J ¼ 1.2), 7.120 (1H, s, H-28),
7.149 (1H, d, H-30, J ¼ 2.7), 7.451e7.417 (1H, dd, H-26, J ¼ 1.8 Hz),
7.726 (1H,d. H-27,
2.091 (1H, m, H-8),
2.02 (1H, m, H-12
1.797 (1H, m, H-15
), 2.832 (1H, m, H-16
5.007 (1H, d, J ¼ 17.4 Hz, H-21A),
2.186 (1H, s, H-23). ESI-MS: m/z ¼ 427, 404,
d
0.999, 1.036 (1H, dd, H-9),
), 1.707 (1H, m, H-12
1.479 (1H, m, H-15
),
d
4.478 (1H, q,
s, CDCl3),
Hz), 1.446 (1H, s, H-19),
CH3-35),
d 0.961 (1H, s, H-18), d
J ¼ 2.7 Hz, H-11),
d
a
d
b
b
),
),
d
d
d
d
d
d
1.75 (1H, m, H-14),
d
a
),
d
d
d
1.479 (1H, m, H-16
a
d
b
d
0.972 (1H, s, H-18),
4.879(1H,
d
d
1.253 (1H, s, H-19),
d
d
J ¼ 17.1, H-21B),
d
d
d, J ¼ 17.4 Hz, H-21B),
d
d
d
d
386, 362, 302.
7.698 (2H, d, H-31, H-32, J ¼ 1.8 Hz),
d
J ¼ 2.4 Hz). FT-IR nmax (in cmꢀ1): 3486, 2948, 2922, 2870, 2850,
1729, 1654, 1608, 1507, 1484, 1458, 1389, 1367, 1324, 12651, 1229,
1181, 1030, 893, 858, 812, 753, 669. ESI-MS: 575, 574, 557, 539, 362,
345, 302.
2.3. Synthesis of 11, 17, 21-trihydroxy-pregn-4-ene-3, 20-dione (2)
Compound 2 was synthesized by dissolving 29 mg (0.071 mmol)
of compound (1) in 1.5 mL of methanol followed by addition of
0.3 mL of sodium methoxide as a catalyst. The mixture was kept at
room temperature for 30 min. The reaction mixture was neutral-
ized with IR 120H þ resin and filtered. Filtrate was concentrated
and compound 2 was purified with column chromatography using
Chloroform/methanol as eluent yielding 27.5 mg (94.82%) of com-
pound 2 in pure state. m.p: 490e491 K, Molecular formula:
2.6. Synthesis of 11, 17-dihydroxy-21-(2-(4-isobutylphenyl)
propionoxy)-pregn-4-ene-3, 20-dione (5)
A solution of ibuprofen 2.2 mg (0.011 mmol), DCC 2.2 mg
(0.011 mmol), DMAP 1.34 mg (0.011 mmol) and compound 2,
4.0 mg (0.011 mmol) in CHCl3 (2 mL) was stirred mechanically at
room temperature for 3e4 h and the progress of reaction was
monitored by TLC. DCU formed during the reaction was filtered off
and the filtrate washed successively with 5% HCl and water, dried
over anhydrous sodium sulphate and filtered. Filtrate obtained was
evaporated under reduced pressure and the crude product was
purified by column chromatography using ethyl acetateehexane
(2:98) as eluent yielding 4.1 mg (66.12%) of compound 5 as solid. M.
P. ¼ 489 K, Molecular formula: C34H46O6, 1H NMR (CDCl3, 300 MHz)
C
21H30O5, 1H NMR in CDCl3 at 300 MHz:
(1H, s, H-18),
1.054, 1.017 (1H, dd, H-9, J ¼ 3.3 Hz),
H-19), 3.061 (1H, broad signal, OH-21),
4.337(1H, d, J ¼ 19.8 Hz,
H-21A),
J ¼ 3 Hz, H-11),
d
7.260(D, s, CDCl3),
d 0.962
d
d
1.442 (1H, s,
d
d
d
4.686 (1H, d, J ¼ 19.8 Hz, H-21B)
d 4.468e4.499 (1H,q,
d
5.689 (1H, d, H-4, J ¼ 1.2 Hz). FT-IR nmax (in cmꢀ1):
3381.44, 2950.5, 2924.74, 2859.79, 1711.34, 1658.76, 1462.88,
1378.35, 1271.13, 1235.05, 1090.72, 1025.77, 869.07, 763.91, 743.29.
ESI-MS: 385, 362, 346, 302.
d
(ppm): 7.24 (2H, dd, H-27 &H-29, J ¼ 8.1, 2.2 Hz), 7.12 (2H, dd, H-
2.4. Synthesis of 11, 17, 21-tri-hydroxy-3, 20-diketo-pregn-1, 4-
diene (3)
26 & H-30, J ¼ 7.8, 1.5 Hz), 5.67 (1H, br s, H-4), 5.11 (1H, d, H-21A,
J ¼ 17.4 Hz) 4.91 (1H, br s, H-17), 4.78 (1H, d, H-21B, J ¼ 17.4 Hz),
4.45 (1H, br d, H-11, J ¼ 3.0 Hz), 3.88e3.80 (1H, m, H-23), 1.56 (3H,
d, CH3-24, J ¼ 7.2 Hz), 1.43 (3H, s, CH3-19), 0.96 (3H, s, CH3-18), 0.90
(6H, d, CH3-33 & CH3-34, J ¼ 6.6 Hz). 13C NMR (CDCl3, 75 MHz)
Mixture of 11,17,21-tri-hydroxy-3,20-diketo-pregn-4-ene (2)
15 mg (0.041 mmol) in 1, 4- dioxane (3 mL) was added 2,3-dichloro-
5,6-dicyano-1,4-benzoquinone (DDQ) (21.0 mg, 0.092 mmol) at
room temperature and the mixture was refluxed for 4 h (progress of
reaction was monitored by TLC). The reaction mixture was cooled
down and filtered, washed with 1, 4-dioxane and concentrated to
give crude product, which was purified by column chromatography
using ethyl acetate: hexane (7:93) to yielding 12.5 mg (83.33%) of
the pure compound. The compound was identified by comparing
its data as reported in literature [13]. Melting Point: 506 K, Mo-
lecular formula: C21H28O5, 1H NMR at 300 MHz (in DMSO-d6)
d
(ppm): 204.77 (C-20), 199.8 (C-3), 174.62 (C-22 & C-5), 140.89 (C-
28), 137.52 (C-25), 129.5 (C-30 & C-26), 127.50 (C-29 & C-27), 122.2
(C-4), 89.84 (C-17), 68.48 (C-11), 68.11 (C-21), 56.50 (C-9) 52.11 (C-
14), 47.75 (C-31), 45.27 (C-13), 45.10 (C-23), 39.42 (C-12), 35.20 (C-
1), 34.84 (C-2), 34.03 (C-6), 32.93 (C-7), 32.22 (C-10), 31.58 (C-16),
30.38 (C-8), 29.92 (C-32), 23.83 (C-19), 22.62 (C-33 & 34), 21.21 (C-
15), 18.92 (C-24), 17.39 (C-18). FT-IR nmax (in cmꢀ1): 3480, 2952,
2930, 2864, 1717, 1657, 1515, 1459, 1411, 1377, 1367, 1229, 1185, 1163,
1127, 1111, 1081, 1055, 1033, 1017, 1003, 973, 943, 897, 861, 785, 743,
697, 645, 545, 523, 499, 457. ESI-MS: m/z ¼ 551, 550, 513, 225.
d
ppm: 7.29 (1H, d, H-1, J ¼ 9.9 Hz), 6.17e6.13 (1H, dd, H-2, J ¼ 1.2,
10.2 Hz), 5.91 (1H, s, H-4), 5.19 (1H, br s, H-17(OH)), 4.70e4.64 (2H,
11-OH, 22-OH), 4.52e4.44 (1H, dd, H-21A, J ¼ 6.0, 19.2 Hz), 4.26
(1H, s, H-11), 4.10e4.02 (1H, dd, H-21B, J ¼ 6.0,19.2 Hz), 1.38 (3H, s,
CH3-19), 0.76 (3H, s, CH3-18).
2.7. Synthesis of 21-(2-(6-methoxynaphthalene-2-yl) propionoxy)
11, 17-di-hydroxy-3, 20-diketo-pregn-1, 4-diene (6)
4.0 mg (0.011 mmol) of 11, 17, 21-tri-hydroxy-3, 20-diketo-
pregn-1, 4-diene (3) was dissolved in 2 mL of chloroform and then
naproxen 2.5 mg (0.011 mmol), DCC 2.2 mg (0.011 mmol) and
DMAP 1.34 mg (0.011 mmol) were added. The reaction mixture was
stirred at room temperature. The completion of reaction was
monitored with the help of thin layer chromatography (TLC). Re-
action mixture was washed with 5% HCl and water, dried over
anhydrous sodium sulphate and filtered. The organic layer was
concentrated under reduced pressure and the crude concentrated
product was purified by column-chromatography using ethyl ace-
tate: hexane (2:98) yielding 4.8 mg (73.84%) of 6 as amorphous.
m.p ¼ 462 K, Molecular formula: C35H40O7, 1H NMR at 300 MHz (in
2.5. Synthesis of 11, 17 dihydroxy-21-(2-(6-methoxynaphthalene-
2yl) propionoxy)-pregn-4-ene-3, 20-dione (4)
4.0 mg (0.011 mmol) of compound 2 (11,17,21-tri-hydroxy-3,20-
diketo-pregn-4-ene), dissolved in 2.5 mL of chloroform and 2.5 mg
(0.011 mmol) of naproxen was added followed by the addition of
1.34 mg (0.011 mmol) of DMAP and 2.2 mg (0.011 mmol) of DCC.
The reaction mixture was stirred at room temperature until reac-
tion was complete. Progress of reaction was monitored by thin layer
chromatography. N, N0 dicyclohexyl urea (DCU) formed as by
product was filtered off and the filtrate was treated with 5% HCl and
water, dried over anhydrous sodium sulphate. Chloroform was
distilled off under reduced pressure. The crude product obtained
was subjected to column chromatography for purification of syn-
thesized compound using silica gel (60e120 mesh) as absorbent
DMSO-d6)
d
ppm: 7.80 (3H, d, H-27, H-31 & H-32, J ¼ 9.6 Hz), 7.45
(1H, d, H-26, J ¼ 8.4 Hz), 7.32 (2H, d, H-30 & H-28, J ¼ 9.0 Hz), 7.17
(1H, d, H-1, J ¼ 9.0 Hz), 6.13 (1H, d, H-2, J ¼ 10.2 Hz), 5.91 (1H, s, H-
4), 5.38 4.90 (1H, br s, H-17(OH)), 5.07 (1H, d, H-21A, J ¼ 17.7 Hz),
Please cite this article in press as: A. Sethi, et al., Facile synthesis of corticosteroids prodrugs from isolated hydrocortisone acetate and their